ATYR Annual CFI
-$20.13 M
-$67.37 M-142.60%
31 December 2023
Summary:
As of January 23, 2025, ATYR annual cash flow from investing activities is -$20.13 million, with the most recent change of -$67.37 million (-142.60%) on December 31, 2023. During the last 3 years, it has fallen by -$27.03 million (-391.70%). ATYR annual CFI is now -142.60% below its all-time high of $47.24 million, reached on December 31, 2022.ATYR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATYR Quarterly CFI
$17.95 M
+$11.22 M+166.74%
01 September 2024
Summary:
As of January 23, 2025, ATYR quarterly cash flow from investing activities is $17.95 million, with the most recent change of +$11.22 million (+166.74%) on September 1, 2024. Over the past year, it has increased by +$11.22 million (+166.74%). ATYR quarterly CFI is now -13.43% below its all-time high of $20.73 million, reached on September 1, 2018.ATYR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATYR TTM CFI
$41.14 M
+$13.56 M+49.19%
01 September 2024
Summary:
As of January 23, 2025, ATYR TTM cash flow from investing activities is $41.14 million, with the most recent change of +$13.56 million (+49.19%) on September 1, 2024. Over the past year, it has increased by +$13.56 million (+49.19%). ATYR TTM CFI is now -12.93% below its all-time high of $47.24 million, reached on December 1, 2022.ATYR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATYR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -142.6% | +166.7% | +49.2% |
| 3 y3 years | -391.7% | +797.8% | -12.9% |
| 5 y5 years | -154.2% | +797.8% | -12.9% |
ATYR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -142.6% | +78.0% | -13.1% | +136.4% | -12.9% | +144.9% |
| 5 y | 5-year | -142.6% | +78.0% | -13.1% | +136.4% | -12.9% | +144.9% |
| alltime | all time | -142.6% | +78.0% | -13.4% | +121.1% | -12.9% | +144.9% |
ATyr Pharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $17.95 M(+166.7%) | $41.14 M(+49.2%) |
| June 2024 | - | $6.73 M(-596.2%) | $27.57 M(+65.2%) |
| Mar 2024 | - | -$1.36 M(-107.6%) | $16.69 M(-182.9%) |
| Dec 2023 | -$20.13 M(-142.6%) | $17.82 M(+306.5%) | -$20.13 M(-44.0%) |
| Sept 2023 | - | $4.38 M(-205.5%) | -$35.95 M(+82.7%) |
| June 2023 | - | -$4.16 M(-89.1%) | -$19.68 M(+254.4%) |
| Mar 2023 | - | -$38.17 M(-2009.6%) | -$5.55 M(-111.8%) |
| Dec 2022 | $47.24 M(-151.6%) | - | - |
| Dec 2022 | - | $2.00 M(-90.3%) | $47.24 M(-1251.8%) |
| Sept 2022 | - | $20.65 M(+107.1%) | -$4.10 M(-89.6%) |
| June 2022 | - | $9.97 M(-31.8%) | -$39.60 M(-26.0%) |
| Mar 2022 | - | $14.63 M(-129.6%) | -$53.55 M(-41.5%) |
| Dec 2021 | -$91.57 M(-1427.0%) | -$49.35 M(+232.3%) | -$91.57 M(+134.7%) |
| Sept 2021 | - | -$14.85 M(+273.7%) | -$39.02 M(+74.0%) |
| June 2021 | - | -$3.97 M(-83.0%) | -$22.43 M(-19.6%) |
| Mar 2021 | - | -$23.39 M(-830.4%) | -$27.90 M(-504.4%) |
| Dec 2020 | $6.90 M(+40.1%) | $3.20 M(+84.1%) | $6.90 M(+178.6%) |
| Sept 2020 | - | $1.74 M(-118.4%) | $2.48 M(-68.8%) |
| June 2020 | - | -$9.45 M(-182.8%) | $7.95 M(-59.6%) |
| Mar 2020 | - | $11.41 M(-1034.9%) | $19.69 M(+299.7%) |
| Dec 2019 | $4.92 M | -$1.22 M(-116.9%) | $4.92 M(+22.8%) |
| Sept 2019 | - | $7.21 M(+214.7%) | $4.01 M(-77.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $2.29 M(-168.3%) | $17.53 M(-21.7%) |
| Mar 2019 | - | -$3.35 M(+57.3%) | $22.40 M(-39.7%) |
| Dec 2018 | $37.17 M(-234.5%) | -$2.13 M(-110.3%) | $37.17 M(+3.9%) |
| Sept 2018 | - | $20.73 M(+189.4%) | $35.77 M(-244.8%) |
| June 2018 | - | $7.16 M(-37.3%) | -$24.71 M(+19.8%) |
| Mar 2018 | - | $11.41 M(-423.3%) | -$20.62 M(-25.4%) |
| Dec 2017 | -$27.64 M(-182.4%) | -$3.53 M(-91.1%) | -$27.64 M(+78.2%) |
| Sept 2017 | - | -$39.76 M(-453.4%) | -$15.51 M(-150.1%) |
| June 2017 | - | $11.25 M(+155.8%) | $30.94 M(+31.5%) |
| Mar 2017 | - | $4.40 M(-48.9%) | $23.53 M(-29.8%) |
| Dec 2016 | $33.53 M(-146.6%) | $8.60 M(+28.6%) | $33.53 M(+16.3%) |
| Sept 2016 | - | $6.69 M(+73.9%) | $28.83 M(-1.9%) |
| June 2016 | - | $3.85 M(-73.3%) | $29.38 M(-149.4%) |
| Mar 2016 | - | $14.39 M(+268.6%) | -$59.43 M(-17.5%) |
| Dec 2015 | -$71.99 M(+3105.4%) | $3.90 M(-46.1%) | -$71.99 M(-1.6%) |
| Sept 2015 | - | $7.24 M(-108.5%) | -$73.15 M(-8.3%) |
| June 2015 | - | -$84.96 M(-4750.4%) | -$79.74 M(-1636.6%) |
| Mar 2015 | - | $1.83 M(-33.6%) | $5.19 M(-331.0%) |
| Dec 2014 | -$2.25 M(+248.8%) | $2.75 M(+323.1%) | -$2.25 M(-55.0%) |
| Sept 2014 | - | $650.00 K(-1810.5%) | -$5.00 M(-11.5%) |
| June 2014 | - | -$38.00 K(-99.3%) | -$5.65 M(+0.7%) |
| Mar 2014 | - | -$5.61 M | -$5.61 M |
| Dec 2013 | -$644.00 K | - | - |
FAQ
- What is aTyr Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for aTyr Pharma?
- What is aTyr Pharma annual CFI year-on-year change?
- What is aTyr Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for aTyr Pharma?
- What is aTyr Pharma quarterly CFI year-on-year change?
- What is aTyr Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for aTyr Pharma?
- What is aTyr Pharma TTM CFI year-on-year change?
What is aTyr Pharma annual cash flow from investing activities?
The current annual CFI of ATYR is -$20.13 M
What is the all time high annual CFI for aTyr Pharma?
aTyr Pharma all-time high annual cash flow from investing activities is $47.24 M
What is aTyr Pharma annual CFI year-on-year change?
Over the past year, ATYR annual cash flow from investing activities has changed by -$67.37 M (-142.60%)
What is aTyr Pharma quarterly cash flow from investing activities?
The current quarterly CFI of ATYR is $17.95 M
What is the all time high quarterly CFI for aTyr Pharma?
aTyr Pharma all-time high quarterly cash flow from investing activities is $20.73 M
What is aTyr Pharma quarterly CFI year-on-year change?
Over the past year, ATYR quarterly cash flow from investing activities has changed by +$11.22 M (+166.74%)
What is aTyr Pharma TTM cash flow from investing activities?
The current TTM CFI of ATYR is $41.14 M
What is the all time high TTM CFI for aTyr Pharma?
aTyr Pharma all-time high TTM cash flow from investing activities is $47.24 M
What is aTyr Pharma TTM CFI year-on-year change?
Over the past year, ATYR TTM cash flow from investing activities has changed by +$13.56 M (+49.19%)